Anzeige
Mehr »
Login
Montag, 18.01.2021 Börsentäglich über 12.000 News von 656 internationalen Medien
Ganz selten: Bewegende Meldung! Wird mit dieser News am Montag ein Super-Hype ausgelöst?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrNewAmsterdam Pharma completes $196m Series A funding for phase 3 development programme
FrPfizer's XALKORI approved by FDA for ALK-positive anaplastic large cell lymphoma in children and young adults
FrNovartis gets FDA breakthrough therapy status for ligelizumab to treat chronic spontaneous urticaria
DoKSQ partners with Takeda to develop immuno-oncology therapies
MiBayer announces FDA accepts NDA and grants priority review for Finerenone for patients with CKD and T2D
MiAmneal to acquire substantially all of Kashiv Specialty Pharmaceuticals
MiGSK, Vir Biotechnology to evaluate neutralising Covid-19 antibody in AGILE study
DiRussian Covid-19 vaccine Sputnik V succeeds in phase 2 trial in India
DiRocket Pharmaceuticals announces buildout of R&D and manufacturing facility to support development of gene therapy pipeline
DiBeiGene announces collaboration with Novartis to develop and commercialize anti-PD-1 antibody Tislelizumab
DiSanofi to buy biopharmaceutical firm Kymab for up to $1.45bn
11.01.GSK, MMV filing for Kozenis in paediatric populations with P. vivax malaria accepted by Australian TGA
11.01.Pfizer says BNT162b2 vaccine is effective against new Covid strains
11.01.Celularity and GX Acquisition announce merger agreement to create publicly listed leader in allogeneic cellular therapy
11.01.Affinivax secures $226m in Series C financing to boost MAPS vaccine pipeline
08.01.Teva, MedinCell announce positive results for registration trial of TV-46000/mdc-IRM for patients with Schizophrenia
08.01.AM-Pharma enrols first patients in Covid-19 phase III trial
08.01.Inversago Pharma receives rare paediatric disease designation from FDA for INV-101 to treat Prader-Willi Syndrome
08.01.Bayer and CureVac collaborate on Covid-19 vaccine candidate
07.01.Xencor, MD Anderson enter collaboration to develop novel T cell-engaging bispecific antibodies for potential treatment of cancer
07.01.RedHill Biopharma's RHB-204 granted FDA fast track designation for NTM disease
07.01.Moderna gets EC conditional marketing authorisation for Covid-19 mRNA vaccine
07.01.Fujifilm to invest $2bn to build large-scale cell culture manufacturing site in US
06.01.LakePharma to manufacture Akston Biosciences' Covid-19 vaccine
06.01.CURE Pharmaceutical receives FDA approval for IND application for erectile dysfunction product CUREfilm Blue
sist1